RAD51C oncogenic variants

About

Biomarker type: Somatic variant

Gene context: RAD51C

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations Biomarkers Cancer types Therapies
FDA (1) RAD51C oncogenic variants Prostate Adenocarcinoma Olaparib
FDA (1) HC (1) RAD51C oncogenic variants Prostate Adenocarcinoma Enzalutamide, Talazoparib